CREATUS BIOSCIENCES
Creatus Biosciences is a green chemical production using proprietary bio-based industrial platform.The company's platform specializes in producing high value low volume chemicals from 2nd generation feedstocks, enabling industries to produce-agnostic xylose utilization as a drop-in solution across a number of industry verticals.
CREATUS BIOSCIENCES
Industry:
Agriculture Biotechnology Life Science Manufacturing
Founded:
2014-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.creatusbio.com
Total Employee:
1+
Status:
Active
Contact:
1 604 691 2271
Email Addresses:
[email protected]
Total Funding:
1.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics WordPress Google Universal Analytics Font Awesome Wordpress Plugins
Similar Organizations
Agriprotein
Agriprotein specializes in nutrient recycling to create sustainable sources of protein for the mono-gastric animal feed industry.
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
hC Bioscience
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
Tierra Biosciences
Tierra Biosciences is a synthetic biology company that offers an AI-driven platform with a vast range of custom proteins for research.
Bolder Industries
Bolder Industries offers advanced manufacturer or sustainable alternatives to carbon black and performance petrochemicals.
Current Employees Featured
Investors List
WUTIF
WUTIF investment in Seed Round - Creatus Biosciences
Creative Destruction Lab (CDL)
Creative Destruction Lab (CDL) investment in Non Equity Assistance - Creatus Biosciences
Official Site Inspections
http://www.creatusbio.com
- Host name: premium67-2.web-hosting.com
- IP address: 198.54.121.137
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "Creatus Biosciences"
Creatus Biosciences Company Profile 2024: Valuation, Funding ...
Creatus Biosciences General Information Description. Developer of proprietary mixed-sugar biorefinery technology designed to produce low-volume chemicals. The company's technology …See details»
Creatus Biosciences Company Profile | Management and
Www.creatusbio.com . Contact Information. Headquarters. 2225 Folkestone Way, Vancouver, British Columbia, V7S 2Y6, Canada (604) 926-8531. Creatus Biosciences Profile and History . …See details»
Creatus Biosciences Inc. - LinkedIn
Creatus Biosciences Inc. is a privately held biotechnology company developing industrially-scalable fermentation processes. The Company’s platform is a novel yeast which possesses a …See details»
Creatus Biosciences - Overview, News & Similar companies
Oct 19, 2021 Creatus Biosciences contact info: Phone number: (604) 926-8531 Website: www.creatusbio.com What does Creatus Biosciences do? Creatus Biosciences Inc. is a …See details»
Creatus Biosciences Inc. Overview | SignalHire Company Profile
Organization Website: creatusbio.com : Creatus Biosciences ... industries Biotech: Headquarters Location: 887 Great Northern Way, Vancouver, British Columbia, V5T CA 887 Great Northern …See details»
Creatus Biosciences Inc. - Company Profile & Staff Directory
Creatus Biosciences Inc. is a privately held biotechnology company focused on the development of industrially-scalable fermentation processes. The Company’s technology platform is based …See details»
FOR IMMEDIATE RELEASE - creatusbio.com
Demonstration of its Xylitol Bioproduction System at an independent contract research organization. Xylitol is a low-calorie sugar alternative, approved by the FDA in 1963, with a …See details»
Creatus Biosciences Inc. - Overview, Competitors, and Employees
Creatus Biosciences is a privately held industrial biotechnology company based in Vancouver, Canada. The company develops scalable, fermentation-based processes using a novel yeast …See details»
Creatus Biosciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Creatus Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Creatus Biosciences - Company Profile - Tracxn
Nov 29, 2024 Creatus Biosciences - Developer of biochemicals using synthetic biology. Raised a total funding of $320K over 2 rounds from 4 investors. Creatus Biosciences has 2871 …See details»
Release_Chris Wagner Appointment - creatusbio.com
1 FOR IMMEDIATE RELEASE: Creatus Biosciences Inc. Appoints Chris Wagner to the Board of Directors Vancouver, BC – September th27, 2022 / Creatus Biosciences Inc. (“Creatus”), an …See details»
Creatus Biosciences Inc. Appoints Chris Wagner to the Board of ...
Sep 30, 2022 Vancouver, BC – September 27th, 2022 / Creatus Biosciences Inc. (“Creatus”), an industrial biotechnology company producing xylitol sweetener from abundant corn wastes, is …See details»
Creatus Biosciences Inc. acquires the exclusive option to IP Assets ...
VANCOUVER, BC , Oct. 20, 2021 /PRNewswire/ - Creatus Biosciences Inc. ("Creatus") have signed a purchase agreement with Virdia, LLC ("Virdia"), a wholly-owned subsidiary of Stora …See details»
Creatus - Virdia_Stora Enso Press Release - creatusbio.com
[email protected] For Hamilton Clark Sustainable Capital (M&A Enquiries): John McKenna CEO and Managing Director [email protected] +1.703.405.0881 About Stora …See details»
Creatus Biosciences Inc. acquires the exclusive option to IP Assets ...
VANCOUVER, BC, Oct. 20, 2021 /PRNewswire/ -- Creatus Biosciences Inc. acquires the exclusive option to IP Assets from Stora Enso to Commercialize Xylitol Bioproduction from …See details»
Creatus Biosciences Inc. acquires the exclusive option to IP
Oct 20, 2021 /CNW/ - Creatus Biosciences Inc. ("Creatus") have signed a purchase agreement with Virdia, LLC ("Virdia"), a wholly-owned subsidiary of Stora Enso Oyj ("Stora...See details»
board of directors Archives - Creatus Biosciences
Vancouver, BC – September 27th, 2022 / Creatus Biosciences Inc. (“Creatus”), an industrial biotechnology company producing xylitol sweetener from abundant corn wastes, is pleased to …See details»
Creatus Biosciences Inc. acquires the exclusive option to IP Assets ...
Vancouver, BC – October 20th, 2021 / Creatus Biosciences Inc. (“Creatus”) have signed a purchase agreement with Virdia, LLC (“Virdia”), a wholly-owned subsidiary of Stora Enso Oyj …See details»
Media Archives - Creatus Biosciences
Vancouver, Canada, January 27, 2020 – Creatus Biosciences Inc. (Creatus), announced today in its 2019 year review that it has received issuance of a core patent related to its Xylitol …See details»